Ibrexafungerp: First Approval

Lee, A

Lee, A (corresponding author), Springer Nat, Private Bag 65901, Auckland 0754, New Zealand.

DRUGS, 2021; 81 (12): 1445

Abstract

Ibrexafungerp (BREXAFEMME(R)) is an orally active triterpenoid antifungal drug being developed by SCYNEXIS, Inc. for the treatment of fungal infection......

Full Text Link